MIRM
Mirum Pharmaceuticals, Inc. Common StockstockNASDAQ
At CloseNov 19, 2026 3:59:52 PM EST
95.53USD+3.281%(+3.04)759,021
Pre-marketNov 19, 2026 9:27:30 AM EST
92.40USD-0.097%(-0.09)
After-hoursNov 19, 2026 4:00:30 PM EST
95.51USD-0.016%(-0.02)
MIRM Financials
In Q3 FY 2026 (ended ), Mirum Pharmaceuticals, Inc. Common Stock (MIRM) reported revenue of $185.72M, net income of −$40.77M, operating cash flow of −$4.31M, and assets of $1.03B (filed ).
Loading financial statements…